Patents by Inventor Aimee L. Eggler

Aimee L. Eggler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7176007
    Abstract: The present invention provides RecA mutant proteins, having either a single mutation or a double mutation. The RecA mutant proteins are highly proficient in both SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein. The single RecA mutant, RecA?C17, has 17 amino acid residues removed from the carboxyl terminus. The double mutant RecA, RecA?C17/E38K, combines the 17 amino acid residue C-terminal deletion of RecA?C17, with a single amino acid change from Glutamate to Lysine at position 38. These RecA mutant proteins are pH sensitive allowing control over formation of products. Hence, methods of using the novel RecA mutants and kits having the RecA mutants as components thereof are also contemplated by the present invention.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: February 13, 2007
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Michael M. Cox, Shelley L. Lusetti, Aimee L. Eggler, Nami Haruta
  • Publication number: 20040157248
    Abstract: The present invention provides RecA mutant proteins, having either a single mutation or a double mutation. The RecA mutant proteins are highly proficient in both SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein. The single RecA mutant, RecA&Dgr;C 17, has 17 amino acid residues removed from the carboxyl terminus. The double mutant RecA, RecA&Dgr;C17/E38K, combines the 17 amino acid residue C-terminal deletion of RecA&Dgr;C17, with a single amino acid change from Glutamate to Lysine at position 38. These RecA mutant proteins are pH sensitive allowing control over formation of products. Hence, methods of using the novel RecA mutants and kits having the RecA mutants as components thereof are also contemplated by the present invention.
    Type: Application
    Filed: December 11, 2003
    Publication date: August 12, 2004
    Inventors: Michael M. Cox, Shelley L. Lusetti, Aimee L. Eggler, Nami Haruta
  • Patent number: 6545043
    Abstract: A method for suppressing target pests, comprising exposing the pests to an effective biopesticidal amount of a composition, the composition comprising a carrier and a purified glucosinolate breakdown product having a hydroxyl group attached, wherein a starting material for the purified glucosinolate breakdown product is isolated from a crambe plant or mustard plant, further wherein the target pests are plants, fungi, bacteria or root knot nematodes is disclosed. Methods for suppressing target pests without limitation as to the starting materials are also disclosed wherein the pests are exposed to an effective biopesticidal amount of a composition comprising a carrier and either an analog or a derivative of a purified glucosinolate breakdown product having a hydroxyl group attached.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: April 8, 2003
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Joel R. Coats, Christopher J. Peterson, Rong Tsao, Aimee L. Eggler, Gregory L. Tylka
  • Patent number: 6207705
    Abstract: The present invention provides novel biopesticides which can replace commercial pesticides and biopesticides which have been banned, restricted, or are being phased out, including, but not limited to chloropicrin, dichlorvos and methyl bromide. Many of the biopesticides of the present invention are excellent fumigants, possessing quick action and volatility, while posing less risk than currently used pesticides to humans and the environment. The biopesticides of the present invention are natural and closely-related synthetic derivatives or analogs related to two classes of natural compounds, namely glucosinolates and monoterpenoids.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: March 27, 2001
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Joel R. Coats, Christopher J. Peterson, Rong Tsao, Aimee L. Eggler, Gregory L. Tylka